Evolent HealthInc. said in a Form 8-K filed April 12 that its board elected MichaelD'Amato as a director to succeed RobertMusslewhite, who submitted his resignation from the board.
Evolent Health is party to a stockholders agreement with TPGGrowth II BDH LP, TPG Eagle Holdings LP, UPMC and The Advisory Board Co., pursuantto which each principal stockholder owning at least 40% of the company's commonstock is entitled to nominate two directors to the board. Musslewhite had been nominatedto the board by The Advisory Board Co., which then nominated D'Amato to serve onthe board.
D'Amato has served as managing partner of Sears Road PartnersLLC since June 2011.